The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir

類似資料

• Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite
  著者:: Damle, Bharat D, 等
  出版事項: (2009)
• Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer
  著者:: Kattel, Krishna, 等
  出版事項: (2015)
• Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status
  著者:: Uno, Tsukasa, 等
  出版事項: (2006)
• Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes
  著者:: Saito, Masato, 等
  出版事項: (2005)
• Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype
  著者:: Geist, Marcus J.P., 等
  出版事項: (2006)